<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="362155">
  <stage>Registered</stage>
  <submitdate>24/02/2012</submitdate>
  <approvaldate>1/05/2012</approvaldate>
  <actrnumber>ACTRN12612000476831</actrnumber>
  <trial_identification>
    <studytitle>Magnetic resonance imaging of the vision centre of the brain in visually impaired versus normally sighted participants</studytitle>
    <scientifictitle>3-Tesla MRI volumetric and diffusion tensor analyses of the primary visual cortex: A case-control study in visually impaired and normally sighted subjects</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Severe visual impairment</healthcondition>
    <conditioncode>
      <conditioncode1>Eye</conditioncode1>
      <conditioncode2>Diseases / disorders of the eye</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Detailed anatomical mapping of the primary cortex using high resolution magnetic resonance imaging in patients with severe visual impairment compared with normally sighted volunteers. Consists of a single brain MRI of the occipital lobe of 60 minutes' duration.</interventions>
    <comparator>Active control: comparison with the primary visual cortex in participants with normal vision</comparator>
    <control>Active</control>
    <interventioncode>Early detection / Screening</interventioncode>
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Provision of a set of algorithmic criteria delineating primary visual cortex structural differences between subjects with visual impairment and those with normal vision.</outcome>
      <timepoint>On completion of the MRI scan</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Nil</outcome>
      <timepoint>Nil</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Cases: untreatable bilateral visual impairment due to retinitis pigmentosa, diabetic retinopathy, glaucoma or macular degeneration or with acquired retinal, optic nerve or ocular surface disease. Visual acuity of less than or equal to Snellens Test Type 6/60 for &gt; 12 months. History of normal vision in adulthood.
Controls: visual acuity of greater than or equal to Snellens Test Type 6/12.
Intact visual cortex 
Age greater than or equal to 18 years</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>History of traumatic occipital cortex injury
Cognitive or intellectual disability, or dementia
Pre-existing active psychiatric conditions including psychosis, bipolar disorder and schizophrenia
Claustrophobia</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Non-randomised trial</allocation>
    <concealment>Allocation is not concealed</concealment>
    <sequence>Not applicable</sequence>
    <masking />
    <assignment>Other</assignment>
    <designfeatures>Two groups, those severely visually impaired, and those will normal vision, receive the same intervention</designfeatures>
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>28/03/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>40</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Monash University</primarysponsorname>
    <primarysponsoraddress>Wellington Road,
Clayton, Victoria, 3800
AUSTRALIA</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Australian Research Council</fundingname>
      <fundingaddress>Level 2, 11 Lancaster Place
Majura Park, ACT, 2609
AUSTRALIA</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>The Alfred</sponsorname>
      <sponsoraddress>Commercial Road, 
Melbourne, Victoria, 3004</sponsoraddress>
      <sponsorcountry>Australia</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>We hypothesise that the structure of the primary visual cortex in severely visually impaired participants will differ from that in participants with normal vision. Our aim is to develop a method of identifying the primary visual cortex during exposure of the occipital lobe of the brain during neurosurgery.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The Alfred Human Research and Ethics Committee</ethicname>
      <ethicaddress>Commercial Road, 
Melbourne, Victoria, 3004</ethicaddress>
      <ethicapprovaldate>1/03/2011</ethicapprovaldate>
      <hrec>44/11</hrec>
      <ethicsubmitdate>12/02/2011</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Ms Helen Ackland</name>
      <address>The Alfred Hospital, 
Commercial Road, 
Prahran, Victoria, 3004</address>
      <phone>61 3 9076 2000</phone>
      <fax />
      <email>h.ackland@alfred.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ms Helen Ackland</name>
      <address>The Alfred Hospital, 
Commercial Road, 
Prahran, Victoria, 3004</address>
      <phone>61 3 9076 2000</phone>
      <fax />
      <email>h.ackland@alfred.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Ms Helen Ackland</name>
      <address>The Alfred Hospital, 
Commercial Road, 
Prahran, Victoria, 3004</address>
      <phone />
      <fax />
      <email>h.ackland@alfred.org.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>